Follow
Immune tolerance
Immune tolerance, or immunotolerance, occurs when the immune response does not activate in response to an insult, such as a virus or infection. Normally, the immune response is activated when it encounters a foreign insult, known as an antigen. Immune tolerance can be beneficial in preventing an immune response against towards self-antigens located in the body which could result in autoimmune diseases.
JUL 12, 2022 | 8:00 AM
Date: July 12, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) Dendritic cells (DCs) are a heterogeneous population of myeloid immune cells that act as peripheral sentinels specializin...
APR 19, 2022 | 12:00 PM
C.E. CREDITS
Loop-mediated isothermal amplification (LAMP) uses a stand-displacing DNA polymerase and four to six primers to rapidly amplify DNA at a single temperature. By eliminating temperature cyclin...
FEB 23, 2022 | 6:00 AM
Cancer still accounts for nearly 1 in every 4 deaths worldwide. New immunotherapies have the power to induce durable responses in patients with fatal cancers, but only a small percentage of...
DEC 09, 2021 | 8:00 AM
Date: December 9, 2021 Time: 8:00am (PDT), 11:00am (EDT) Engineering human regulatory T cells (Tregs) with a chimeric antigen receptor (CAR) targeting donorderived human leukocyte antigen (H...
NOV 30, 2021 | 7:00 AM
Date: November 30, 2021 Time: 7:00am (PDT), 10:00am (EDT) Wastewater Surveillance programs for SARS-CoV-2 are being implemented by health authorities globally. Many laboratories are currentl...
OCT 28, 2021 | 9:00 AM
Date: October 28, 2021 Time: 9:00am (PDT), 12:00pm (EDT) Loop-mediated isothermal amplification (LAMP) uses a stand-displacing DNA polymerase and four to six primers to rapidly amplify DNA a...
JUN 09, 2021 | 8:00 AM
DATE: June 9, 2021 TIME: 8:00am PDT Analyzing antigen-specific T cells is essential to understand fundamental immunological processes in the contexts of immuno-oncology, infectious dise...
JUN 02, 2021 | 10:30 AM
Learning Objectives: 1. Understand how the outcome of PD-1 blockade is a summation of increased Teffector activity and increased Treg suppressive activity 2. Explain how PD-1 blockade leads...
JUN 02, 2021 | 12:00 AM
Learning Objectives: 1. Learn about IDO pathway 2. IDO rule in cancer...
APR 21, 2021 | 12:00 AM
Engineered cell therapy is an emerging field of science to target and treat cancer. Current strategies include utilizing immune cells such as T cells, NK cells and Macrophages or other cells...
MAR 16, 2021 | 8:00 AM
DATE: March 09, 2021 TIME: 08:00am PST The COVID-19 pandemic has placed urgency on precise analysis of rare antigen- and virus-specific T cells. At Miltenyi Biotec, we offer a complete workf...
FEB 10, 2021 | 12:00 AM
Primates have been essential in unlocking novel immune mechanisms that have driven development of groundbreaking new drugs in infectious disease and transplantation, amongst others related t...
JAN 27, 2021 | 9:00 AM
DATE: January 27, 2021 TIME: 9am PST Well-timed interaction of correctly functioning maternal immune cells is essential to facilitate healthy placenta formation, as the uterine immune enviro...
SEP 08, 2020 | 11:00 PM
The receptor binding domain (RBD) of the SARS-CoV-2 spike glycoprotein mediates viral attachment to ACE2 receptor, and is a major determinant of host range and a dominant target of neutraliz...
